319 related articles for article (PubMed ID: 11899120)
1. The greater impact of menopause on ER- than ER+ breast cancer incidence: a possible explanation (United States).
Tarone RE; Chu KC
Cancer Causes Control; 2002 Feb; 13(1):7-14. PubMed ID: 11899120
[TBL] [Abstract][Full Text] [Related]
2. Age-specific incidence of breast cancer subtypes: understanding the black-white crossover.
Clarke CA; Keegan TH; Yang J; Press DJ; Kurian AW; Patel AH; Lacey JV
J Natl Cancer Inst; 2012 Jul; 104(14):1094-101. PubMed ID: 22773826
[TBL] [Abstract][Full Text] [Related]
3. Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.
Kohler BA; Sherman RL; Howlader N; Jemal A; Ryerson AB; Henry KA; Boscoe FP; Cronin KA; Lake A; Noone AM; Henley SJ; Eheman CR; Anderson RN; Penberthy L
J Natl Cancer Inst; 2015 Jun; 107(6):djv048. PubMed ID: 25825511
[TBL] [Abstract][Full Text] [Related]
4. Breast cancer incidence in black and white women stratified by estrogen and progesterone receptor statuses.
Gleason MX; Mdzinarishvili T; Sherman S
PLoS One; 2012; 7(11):e49359. PubMed ID: 23166647
[TBL] [Abstract][Full Text] [Related]
5. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.
Howlader N; Altekruse SF; Li CI; Chen VW; Clarke CA; Ries LA; Cronin KA
J Natl Cancer Inst; 2014 Apr; 106(5):. PubMed ID: 24777111
[TBL] [Abstract][Full Text] [Related]
6. Incidence of invasive breast cancer by hormone receptor status from 1992 to 1998.
Li CI; Daling JR; Malone KE
J Clin Oncol; 2003 Jan; 21(1):28-34. PubMed ID: 12506166
[TBL] [Abstract][Full Text] [Related]
7. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
[TBL] [Abstract][Full Text] [Related]
8. Rates for breast cancer characteristics by estrogen and progesterone receptor status in the major racial/ethnic groups.
Chu KC; Anderson WF
Breast Cancer Res Treat; 2002 Jun; 74(3):199-211. PubMed ID: 12206512
[TBL] [Abstract][Full Text] [Related]
9. The shape of age-incidence curves of female breast cancer by hormone-receptor status.
Yasui Y; Potter JD
Cancer Causes Control; 1999 Oct; 10(5):431-7. PubMed ID: 10530614
[TBL] [Abstract][Full Text] [Related]
10. Racial comparison of receptor-defined breast cancer in Southern African women: subtype prevalence and age-incidence analysis of nationwide cancer registry data.
Dickens C; Duarte R; Zietsman A; Cubasch H; Kellett P; Schüz J; Kielkowski D; McCormack V
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2311-21. PubMed ID: 25143359
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer receptor status and stage at diagnosis in over 1,200 consecutive public hospital patients in Soweto, South Africa: a case series.
McCormack VA; Joffe M; van den Berg E; Broeze N; Silva Idos S; Romieu I; Jacobson JS; Neugut AI; Schüz J; Cubasch H
Breast Cancer Res; 2013; 15(5):R84. PubMed ID: 24041225
[TBL] [Abstract][Full Text] [Related]
12. Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma.
Anderson WF; Chu KC; Chang S; Sherman ME
Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1128-35. PubMed ID: 15247123
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for breast cancer according to estrogen and progesterone receptor status.
Colditz GA; Rosner BA; Chen WY; Holmes MD; Hankinson SE
J Natl Cancer Inst; 2004 Feb; 96(3):218-28. PubMed ID: 14759989
[TBL] [Abstract][Full Text] [Related]
14. Temporal trends in the black/white breast cancer case ratio for estrogen receptor status: disparities are historically contingent, not innate.
Krieger N; Chen JT; Waterman PD
Cancer Causes Control; 2011 Mar; 22(3):511-4. PubMed ID: 21188492
[TBL] [Abstract][Full Text] [Related]
15. Age-dependent changes in breast cancer hormone receptors and oxidant stress markers.
Quong J; Eppenberger-Castori S; Moore D; Scott GK; Birrer MJ; Kueng W; Eppenberger U; Benz CC
Breast Cancer Res Treat; 2002 Dec; 76(3):221-36. PubMed ID: 12462383
[TBL] [Abstract][Full Text] [Related]
16. Recent trends in breast cancer among younger women in the United States.
Brinton LA; Sherman ME; Carreon JD; Anderson WF
J Natl Cancer Inst; 2008 Nov; 100(22):1643-8. PubMed ID: 19001605
[TBL] [Abstract][Full Text] [Related]
17. Hormone receptor status of breast tumors in black, Hispanic, and non-Hispanic white women. An analysis of 13,239 cases.
Gapstur SM; Dupuis J; Gann P; Collila S; Winchester DP
Cancer; 1996 Apr; 77(8):1465-71. PubMed ID: 8608530
[TBL] [Abstract][Full Text] [Related]
18. Underlying causes of the black-white racial disparity in breast cancer mortality: a population-based analysis.
Menashe I; Anderson WF; Jatoi I; Rosenberg PS
J Natl Cancer Inst; 2009 Jul; 101(14):993-1000. PubMed ID: 19584327
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor positive tumors: do reproductive factors explain differences in incidence between black and white women?
Warner ET; Tamimi RM; Boggs DA; Rosner B; Rosenberg L; Colditz GA; Palmer JR
Cancer Causes Control; 2013 Apr; 24(4):731-9. PubMed ID: 23380944
[TBL] [Abstract][Full Text] [Related]
20. Age/race differences in HER2 testing and in incidence rates for breast cancer triple subtypes: a population-based study and first report.
Lund MJ; Butler EN; Hair BY; Ward KC; Andrews JH; Oprea-Ilies G; Bayakly AR; O'Regan RM; Vertino PM; Eley JW
Cancer; 2010 Jun; 116(11):2549-59. PubMed ID: 20336785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
